On June 04, 2014, Judge Sara Ellis entered an order granting final approval of a class action settlement and notice to the settlement class in the matter Satterfield v. Lime Energy Co. (NASDAQ:LIME) Case No. 12-cv-05704. As part of the settlement, Defendants agreed to pay $2.5 million into a settlement fund, the entire amount of which they anticipate will be covered by insurance. Lime Energy Co. (NASDAQ:LIME) net profit margin is -49.00% and weekly performance is -4.53%. On last trading day company shares ended up $2.53. Lime Energy Co. (NASDAQ:LIME) distance from 50-day simple moving average (SMA50) is -13.85%.
Finjan Holdings, Inc. (NASDAQ:FNJN) technology company committed to enabling innovation through the licensing of its intellectual property, provides an update to clarify a recent docket order in the matter of Finjan, Inc. v. FireEye, Inc. (civ. no. 4:13-cv-03133 SBA) in the United States District Court for the Northern District of California, in which the Court corrected an error in the official Docket. Specifically, Docket No. 74 (June 6, 2014), entitled “AMENDED Report on the Filing or Determination of an Action Regarding a Patent or Trademark” corrected an earlier filed report (Docket No. 73, June 4, 2014) for an “Order of Dismissal.” The newly updated Docket No. 74 entry is an Order for Stay pending reexamination of Finjan’s U.S. Patent Nos. 7,058,822 and 7,647,633.
Finjan Holdings, Inc. (NASDAQ:FNJN) shares ended the day on $4.00. FNJN gross Margin is -14.30% and its return on assets is -26.30%.Finjan Holdings, Inc. (NASDAQ:FNJN) quarterly performance is -28.95%.
Hardinge Inc. (NASDAQ:HDNG) announced on 8 May, net loss for the three months ended March 31, 2014 was $0.5 million, or 0.6% of net sales, compared to net income of $0.0 million, or 0.1% of net sales, for the same period in 2013. Hardinge Inc. (NASDAQ:HDNG) shares moved down -1.01% in last trading session and was closed at $11.79, while trading in range of $11.77 – $11.94. Hardinge Inc. (NASDAQ:HDNG) year to date (YTD) performance is -18.30%.
MGC Diagnostics Corp (NASDAQ:MGCD) posted its quarterly earnings results on Thursday. The company reported $0.07 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.13 by $0.06, AnalystRatingsNetwork reports. MGC Diagnostics Corp (NASDAQ:MGCD) ended the last trading day at $8.86. Company weekly volatility is calculated as 6.98% and price to cash ratio as 3.36.MGC Diagnostics Corp (NASDAQ:MGCD) showed a negative weekly performance of -3.17%.
The Female Health Company (NASDAQ:FHCO) on 19 may, announced a repurchase of 35,000 shares of its outstanding common stock under the Company’s stock repurchase program. The program has a repurchase cap of three million shares of common stock and expires on December 31, 2014. The Company has repurchased approximately 2.1 million shares under the program, and approximately 0.9 million shares remain for potential repurchase. The Female Health Company (NASDAQ:FHCO) net profit margin is 39.80% and weekly performance is -5.02%. On last trading day company shares ended up $5.49. The Female Health Company (NASDAQ:FHCO) distance from 50-day simple moving average (SMA50) is -18.17%.